Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Insect Biochem Mol Biol ; 122: 103393, 2020 07.
Artículo en Inglés | MEDLINE | ID: mdl-32360958

RESUMEN

In sandflies, males and females feed on carbohydrates but females must get a blood meal for egg maturation. Using artificial blood meals, this study aimed to understand how galactosamine interferes with sandfly digestive physiology. We also used galactosamine to manipulate the digestive physiology of Lutzomyia longipalpis to investigate its influence on sandfly digestion and Leishmania development within their insect vectors. Galactosamine was capable to reduce Lu. longipalpis trypsinolytic activity in a dose-dependent manner. This effect was specific to galactosamine as other similar sugars were not able to affect sandfly trypsin production. An excess of amino acids supplemented with the blood meal and 15 mM galactosamine was able to abrogate the reduction of the trypsinolytic activity caused by galactosamine, suggesting this phenomenon may be related to an impairment of amino acid detection by sandfly enterocytes. The TOR inhibitor rapamycin reduces trypsin activity in the L. longipalpis midgut. Galactosamine reduces the phosphorylation of the TOR pathway repressor 4EBP, downregulating TOR activity in the gut of L. longipalpis. Galactosamine reduces sandfly oviposition, causes an impact on sandfly longevity and specifically reduces sandfly gut proteases whereas increasing α-glycosidase activity. The administration of 15 and 30 mM galactosamine increased the number of promastigote forms of Le. mexicana and Le. infantum in galactosamine-treated L. longipalpis. Our results showed that galactosamine influences amino acid sensing, reduces sandfly gut protease activity through TOR downregulation, and benefits Leishmania growth within the Lu. longipalpis gut.


Asunto(s)
Galactosamina/administración & dosificación , Proteínas de Insectos/metabolismo , Leishmania/fisiología , Péptido Hidrolasas/metabolismo , Psychodidae/efectos de los fármacos , Serina-Treonina Quinasas TOR/metabolismo , Animales , Regulación hacia Abajo , Femenino , Galactosamina/farmacología , Tracto Gastrointestinal/parasitología , Tracto Gastrointestinal/fisiología , Psychodidae/enzimología , Psychodidae/parasitología
2.
J Pharm Pharmacol ; 53(4): 505-11, 2001 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-11341367

RESUMEN

The effects of 1,8-cineole on D-galactosamine/lipopolysaccharide (GalN/LPS)-induced shock model of liver injury was investigated in mice. The co-administration of GalN (700 mg kg(-1), i.p.) and LPS (5 microg kg(-1), i.p.) greatly elevated serum concentrations of tumour necrosis factor-alpha (TNF-alpha), alanine aminotransferase and aspartate aminotransferase, and induced massive hepatic necrosis and lethality in 100% of control mice. Pretreatment with 1,8-cineole (400 mg kg(-1), p.o.) and dexamethasone (1 mg kg(-1), s.c.), 60 min before GalN/LPS, offered complete protection (100%) against the lethal shock and acute elevation in serum TNF-alpha and serum transaminases. Hepatic necrosis induced by GalN/LPS was also greatly reduced by both 1,8-cineole and dexamethasone treatment. The results indicate that 1,8-cineole protects mice against GalN/LPS-induced liver injury through the inhibition of TNF-alpha production, and suggest that 1,8-cineole may be a promising agent to combat septic-shock-associated pathologies.


Asunto(s)
Ciclohexanoles , Fallo Hepático/prevención & control , Mentol/análogos & derivados , Mentol/farmacología , Monoterpenos , Choque Séptico/fisiopatología , Solventes/farmacología , Terpenos , Animales , Modelos Animales de Enfermedad , Eucaliptol , Galactosamina/administración & dosificación , Galactosamina/efectos adversos , Lipopolisacáridos/administración & dosificación , Lipopolisacáridos/efectos adversos , Fallo Hepático/etiología , Masculino , Ratones , Choque Séptico/complicaciones , Transaminasas/biosíntesis , Transaminasas/metabolismo , Factor de Necrosis Tumoral alfa/biosíntesis
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA